Literature DB >> 26874884

Reduced Short- and Long-Latency Afferent Inhibition Following Acute Muscle Pain: A Potential Role in the Recovery of Motor Output.

Emma Burns1, Lucinda Sian Chipchase1, Siobhan May Schabrun1.   

Abstract

OBJECTIVE: Corticomotor output is reduced in response to acute muscle pain, yet the mechanisms that underpin this effect remain unclear. Here the authors investigate the effect of acute muscle pain on short-latency afferent inhibition, long-latency afferent inhibition, and long-interval intra-cortical inhibition to determine whether these mechanisms could plausibly contribute to reduced motor output in pain.
DESIGN: Observational same subject pre-post test design.
SETTING: Neurophysiology research laboratory.
SUBJECTS: Healthy, right-handed human volunteers (n = 22, 9 male; mean age ± standard deviation, 22.6 ± 7.8 years).
METHODS: Transcranial magnetic stimulation was used to assess corticomotor output, short-latency afferent inhibition, long-latency afferent inhibition, and long-interval intra-cortical inhibition before, during, immediately after, and 15 minutes after hypertonic saline infusion into right first dorsal interosseous muscle. Pain intensity and quality were recorded using an 11-point numerical rating scale and the McGill Pain Questionnaire.
RESULTS: Compared with baseline, corticomotor output was reduced at all time points (p = 0.001). Short-latency afferent inhibition was reduced immediately after (p = 0.039), and long-latency afferent inhibition 15 minutes after (p = 0.035), the resolution of pain. Long-interval intra-cortical inhibition was unchanged at any time point (p = 0.36).
CONCLUSIONS: These findings suggest short- and long-latency afferent inhibition, mechanisms thought to reflect the integration of sensory information with motor output at the cortex, are reduced following acute muscle pain. Although the functional relevance is unclear, the authors hypothesize a reduction in these mechanisms may contribute to the restoration of normal motor output after an episode of acute muscle pain.
© 2016 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Experimental Muscle Pain; Long-Interval Intracortical Inhibition; Long-Latency Afferent Inhibition; Sensorimotor Integration; Short-Latency Afferent Inhibition; Transcranial Magnetic Stimulation

Year:  2016        PMID: 26874884     DOI: 10.1093/pm/pnv104

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  6 in total

1.  Modulation of long-latency afferent inhibition by the amplitude of sensory afferent volley.

Authors:  Claudia V Turco; Jenin El-Sayes; Hunter J Fassett; Robert Chen; Aimee J Nelson
Journal:  J Neurophysiol       Date:  2017-04-26       Impact factor: 2.714

2.  Short-latency afferent inhibition determined by the sensory afferent volley.

Authors:  Aaron Z Bailey; Michael J Asmussen; Aimee J Nelson
Journal:  J Neurophysiol       Date:  2016-05-25       Impact factor: 2.714

3.  Differential Corticomotor Excitability Responses to Hypertonic Saline-Induced Muscle Pain in Forearm and Hand Muscles.

Authors:  Dennis B Larsen; Thomas Graven-Nielsen; Rogerio P Hirata; Shellie A Boudreau
Journal:  Neural Plast       Date:  2018-04-22       Impact factor: 3.599

4.  The effect of IPC on central and peripheral fatiguing mechanisms in humans following maximal single limb isokinetic exercise.

Authors:  Samuel L Halley; Paul Marshall; Jason C Siegler
Journal:  Physiol Rep       Date:  2019-04

5.  Effect of Experimental Cutaneous Hand Pain on Corticospinal Excitability and Short Afferent Inhibition.

Authors:  Catherine Mercier; Martin Gagné; Karen T Reilly; Laurent J Bouyer
Journal:  Brain Sci       Date:  2016-09-29

6.  Impact of Experimental Tonic Pain on Corrective Motor Responses to Mechanical Perturbations.

Authors:  Elodie Traverse; Clémentine Brun; Émilie Harnois; Catherine Mercier
Journal:  Neural Plast       Date:  2020-07-31       Impact factor: 3.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.